A new trading day began on Friday, with Guardant Health Inc (NASDAQ: GH) stock price down -3.64% from the previous day of trading, before settling in for the closing price of $30.21. GH’s price has ranged from $15.81 to $37.04 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 49.27%. Meanwhile, its annual earnings per share averaged 19.46%. With a float of $117.81 million, this company’s outstanding shares have now reached $121.63 million.
Let’s determine the extent of company efficiency that accounts for 1779 employees. In terms of profitability, gross margin is 81.07%, operating margin of -74.41%, and the pretax margin is -74.02%.
Guardant Health Inc (GH) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Guardant Health Inc is 4.32%, while institutional ownership is 102.99%. The most recent insider transaction that took place on Nov 13 ’24, was worth 86,595. In this transaction Director of this company sold 2,896 shares at a rate of $29.90, taking the stock ownership to the 7,648 shares. Before that another transaction happened on Nov 12 ’24, when Company’s Director sold 8,318 for $29.45, making the entire transaction worth $244,930. This insider now owns 8,435 shares in total.
Guardant Health Inc (GH) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.64 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.55 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 19.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.20% during the next five years compared to -8.88% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Here are Guardant Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.85. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.24, a number that is poised to hit -0.78 in the next quarter and is forecasted to reach -2.96 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Looking closely at Guardant Health Inc (NASDAQ: GH), its last 5-days average volume was 2.36 million, which is a jump from its year-to-date volume of 2.08 million. As of the previous 9 days, the stock’s Stochastic %D was 68.90%. Additionally, its Average True Range was 1.66.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 53.08%, which indicates a significant decrease from 63.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.68% in the past 14 days, which was higher than the 61.54% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $23.68, while its 200-day Moving Average is $24.25. However, in the short run, Guardant Health Inc’s stock first resistance to watch stands at $30.19. Second resistance stands at $31.28. The third major resistance level sits at $31.89. If the price goes on to break the first support level at $28.50, it is likely to go to the next support level at $27.89. Now, if the price goes above the second support level, the third support stands at $26.81.
Guardant Health Inc (NASDAQ: GH) Key Stats
With a market capitalization of 3.47 billion, the company has a total of 123,555K Shares Outstanding. Currently, annual sales are 563,950 K while annual income is -479,450 K. The company’s previous quarter sales were 191,480 K while its latest quarter income was -107,750 K.
